What is in this article?:
Deal is significant news for the global nutritional ingredients market because it represents DSM’s largest nutrition investment since the company purchased Roche’s vitamins and fine chemicals division in 2002. Perhaps more significantly, it adds to the competition and complexity of the global omega-3 market.
Who is next?
As Functional Ingredients magazine's editor-in-chief, Todd Runestad, notes, DSM's purchase of Martek isn't likely to be the last deal of its kind in the omega-3 market. "I'm eager to see what else happens in 2011," Runestad said.
Krill oil supplier Neptune could possibly be at the top of the acquisition list, Runestad added. Meanwhile, smaller omega-3 companies are likely to be "trembling in their boots" given that a global player such as DSM is now even larger.